MPLTMapLight Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18722
Ticker: MPLT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-10-27
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MPLT

Detail

Enriched 2026-08-14 20:47

Market cap: $516,033,792.88
Shares outstanding (class): 42,618,165
Shares outstanding (weighted): 45,345,676
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 133
Location: REDWOOD CITY, CA
Homepage: https://www.maplightrx.com
Description: MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Market cap and share counts drift.

Funds holding this security

61 funds · 61 positions · $66.79M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$12.72M	0.16%	625,724 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$12.63M	0.14%	621,328 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$9.73M	0.00%	478,579 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$9.41M	0.01%	462,841 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$6.96M	0.16%	342,343 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.58M	0.01%	225,458 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$1.68M	0.01%	82,717 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.65M	0.01%	81,336 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$991.1K	0.08%	48,750 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$953.5K	0.01%	46,903 NS	FIGI
Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC	—	$871.3K	0.15%	42,858 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$581.0K	0.01%	28,580 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$429.4K	0.01%	21,120 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$287.5K	0.01%	14,143 NS	FIGI
Lazard US Small Cap Equity Select Portfolio LAZARD FUNDS INC	—	$270.3K	0.83%	13,294 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMPLT
FIGI_COMPOSITEBBG01JZ5DBQ0
FIGI_SHARE_CLASSBBG01JZ5DBS8
CIK0001770069
ISINUS56565P1030
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals based on SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.